SEARCH

SEARCH BY CITATION

References

  • 1
    Kubo S , Nishiguchi S , Shuto T , Tanaka H , Tsukamoto T , Hirohashi K et al. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 1999; 90: 16270.
  • 2
    Kubo S , Hirohashi K , Tanaka H , Tsukamoto T , Shuto T , Ikebe T et al. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg 2000; 24: 155965.
  • 3
    Nishiguchi S , Kuroki T , Nakatani S , Morimoto H , Takeda T , Nakajima S et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 10515.
  • 4
    Kubo S , Nishiguchi S , Hirohashi K , Tanaka H , Shuto T , Yamazaki O et al. Effects of long-term postoperative interferon-α on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001; 134: 9637.
  • 5
    Nishiguchi S , Shiomi S , Nakatani S , Takeda T , Fukuda K , Tamori A et al. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 2001; 357: 1967.
  • 6
    Takenaka K , Yamamoto K , Taketomi A , Itasaka H , Adachi E , Shirabe K et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995; 22: 204.
  • 7
    Pugh RNH , Murray-Lyon IM , Dawson JL , Pietroni MC , Williams R . Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 6469.
  • 8
    Desmet VJ , Gerber M , Hoofnagle JH , Manns M , Scheuer PJ . Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 151320.
  • 9
    Kubo S , Nishiguchi S , Hirohashi K , Shuto T , Kuroki T , Minamitani S et al. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn J Cancer Res 1998; 89: 41926.
  • 10
    Kubo S , Yamamoto T , Ikebe T , Shuto T , Hirohashi K , Tanaka H et al. Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C. Jpn J Cancer Res 1999; 90: 107680.
  • 11
    Yoshida H , Shiratori Y , Moriyama M , Arakawa Y , Ide T , Sata M et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999; 131: 17481.
  • 12
    Shiratori Y , Imazeki F , Moriyama M , Yano M , Arakawa Y , Yokosuka O et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132: 51724.
  • 13
    Dunk AA , Ikeda T , Pignatelli M , Thomas HC . Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma. J Hepatol 1986; 2: 41929.
  • 14
    Baron S , Tyring SK , Fleischmann WR , Coppenhauer DH , Niesel DW , Klimpel GR et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266: 137583.
  • 15
    Singh RK , Gutman M , Bucana CD , Sanchez R , Llansa N , Fidler IJ . Interferon alfa and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci U S A 1995; 92: 45626.
  • 16
    Ikeda K , Arase Y , Saitoh S , Kobayashi M , Suzuki Y , Suzuki F et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 22832.
  • 17
    Lai C-L , Lau JYN , Wu P-C , Ngan H , Chung H-T , Mitchell SJ et al. Recombinant interferon-α in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 1993; 13: 38994.
  • 18
    Shimada M , Takenaka K , Gion T , Fujiwara Y , Kajiyama K , Maeda T et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 7206.
  • 19
    Hirohashi K , Shuto T , Kubo S , Tanaka H , Yamamoto T , Ikebe T et al. Prognostic factors after recurrence of resected hepatocellular carcinoma associated with hepatitis C virus. J Hepatobiliary Pancreat Surg 2001; 8: 816.
  • 20
    Serfaty L , Aumaître H , Chazouillères O , Bonnand A-M , Rosmorduc O , Poupon RE et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998; 27: 143540.